To understand why this matters, it helps to look at how CAPA-IVM differs from conventional in vitro fertilization. Standard IVF relies on controlled ovarian stimulation, in which women receive daily injections of gonadotropins to mature many eggs inside the body before retrieval. That stimulation carries a well-known danger: ovarian hyperstimulation syndrome, or OHSS, a potentially serious condition driven by vascular endothelial growth factor and excessive luteal stimulation. Strategies such as triggering final egg maturation with a gonadotropin-releasing hormone agonist instead of hCG, and freezing all embryos for transfer in a later cycle, have reduced but never fully eliminated this risk. IVM takes a more radical approach by skipping stimulation almost entirely. Immature eggs are retrieved from small follicles of just two to eight millimeters and matured in the laboratory under low-dose hormones, followed by intracytoplasmic sperm injection.

Conventional IVM, however, has historically lagged behind IVF in success rates, partly because the retrieved cohort of eggs matures in a dys-synchronized fashion. CAPA-IVM addresses this with a pre-maturation phase lasting roughly 24 hours, in which C-type natriuretic peptide keeps the eggs in meiotic arrest by maintaining elevated cyclic AMP levels inside the surrounding cumulus cells. This pause allows nuclear and cytoplasmic maturation to proceed in step. A subsequent 30-hour maturation phase with follicle-stimulating hormone and amphiregulin then drives development forward. A landmark randomized controlled trial published in 2020 compared CAPA-IVM with conventional IVF in 546 women with high antral follicle counts. Although live birth rates after the first transfer were somewhat lower with CAPA-IVM, at 35.2 percent versus 43.2 percent, the technique produced zero cases of OHSS, required far less medication, and showed no increase in neonatal complications or developmental delays in follow-up studies of children born through the method.

Despite these clinical advantages, CAPA-IVM faces a practical bottleneck: embryo selection. Because the technique yields fewer embryos than stimulated IVF, choosing the single best candidate for transfer carries extra weight. Since the late 1990s, time-lapse monitoring has offered a way to watch embryos develop continuously inside the incubator, photographing them at regular intervals without removing them from their culture environment. This produces a rich record of morphokinetics, the exact timing of events such as the first cell divisions, compaction, and the onset of blastulation. Around the world, artificial intelligence has been layered onto this data stream, with deep learning systems such as IVY and iDAscore demonstrating that algorithms can rank embryos and predict implantation with accuracy that rivals or exceeds human embryologists.

What has been missing, until now, is any AI model built specifically for CAPA-IVM embryos, whose developmental trajectories may differ from those of stimulated IVF embryos because they originate from small, unstimulated follicles. The Vietnamese team, a collaboration between the Hope Research Center at My Duc Hospital and the Laboratory of AI and Computer Vision at the University of Arkansas, set out to fill that gap. Their retrospective cohort study ran from March 2021 to December 2023 and included 81 women aged 18 to 37 with polycystic ovarian morphology who underwent CAPA-IVM. Embryos were cultured to the blastocyst stage in an Astec time-lapse incubator capturing images every 15 minutes, then cryopreserved for later frozen transfer.

The researchers assembled a carefully balanced dataset of 100 embryos: 50 that resulted in a live birth at or beyond 24 weeks of gestation with a healthy newborn, and 50 that did not, matched by comparable female age. From each embryo’s time-lapse video, they extracted frames using Python and OpenCV and annotated both morphological grades and a battery of morphokinetic timings, following ESHRE recommendations and the Istanbul Consensus guidelines. The predictor variables included the times to pronuclear appearance and fading, the two-cell, four-cell, and five-cell stages, the start of compaction, the morula stage, and the start of blastulation, alongside embryo grade, the proportion of mature metaphase II oocytes, maternal age and body mass index, infertility type, and the total number of embryos frozen per cycle.

The core experiment tested a deceptively simple question: does an algorithm need all eight morphokinetic parameters to predict live birth, or can a stripped-down set of four do the job just as well? Four supervised learning algorithms were pitted against each other under both feature specifications: logistic regression, decision tree, gradient boosting, and XGBoost. Hyperparameters were tuned through exhaustive grid search with repeated stratified five-fold cross-validation, repeated ten times, and the area under the receiver operating characteristic curve served as the primary metric. The results revealed an instructive pattern. With the reduced four-parameter feature set, the decision tree model led the field, reaching 80 percent test accuracy and a ROC AUC of 0.775, with perfect recall on live birth cases. With the full eight-parameter set, XGBoost took the crown, matching the 80 percent accuracy but pushing the ROC AUC to 0.82.

The interpretability analysis proved as revealing as the raw performance numbers. Using SHAP values, a technique that quantifies each feature’s contribution to individual predictions, the researchers found that embryo morphological grade dominated both models, with Grade 3 embryos far less likely to end in live birth. In the reduced model, the timing of the four-cell stage emerged as a key early marker of developmental competence, along with the MII oocyte rate and body mass index. In the full model, later events such as the start of compaction, the two-cell timing, and the five-cell timing added predictive value, suggesting that algorithms capable of handling nonlinear interactions can squeeze extra signal from dense developmental trajectories. Notably, the two best models delivered performance competitive with published IVF embryo-ranking systems, which typically report ROC AUC values between 0.65 and 0.75, a striking result for a first attempt in the IVM setting.

The practical implications reach well beyond the statistics. If four carefully chosen timing markers capture most of the clinically relevant information, embryology laboratories could dramatically reduce the annotation workload that comprehensive morphokinetic tracking demands, improving reproducibility across centers and lowering the barrier to adopting AI-assisted selection. Simpler models with fewer, more interpretable inputs are also easier for clinicians to trust and integrate into daily decision-making, particularly for patients with polycystic ovary syndrome, who stand to benefit most from CAPA-IVM’s hormone-light approach. The authors caution, however, that this was a retrospective, single-center study with a modest sample of 100 embryos, some of which were nested within the same couples, and that external validation on larger, independent, multicenter datasets remains an essential next step before clinical deployment.

Even with those caveats, the study marks a meaningful convergence of two trends in reproductive medicine: the shift toward gentler, safer stimulation protocols, and the rise of machine learning as an objective arbiter of embryo quality. For the millions of women with PCOS or high antral follicle counts who face an elevated risk of ovarian hyperstimulation, a future in which an algorithm watches their embryos divide and flags the most promising candidate, all without a single day of heavy hormone injections, is moving from speculation toward the laboratory bench. As validation studies multiply, the humble decision tree and its gradient-boosted rival may become quiet workhorses of the modern fertility clinic, turning the silent choreography of cell division into a data-driven verdict on which embryo deserves its chance at life.

Subject of Research: Machine learning prediction of live birth outcomes for CAPA-IVM blastocyst embryos using time-lapse morphokinetic parameters

Article Title: Selection of capacitation in-vitro maturation (CAPA–IVM) blastocyst embryos by a machine learning prediction model using the morpho-kinetics

Article References: Dang, A., Nguyen, T., Lam, H., Nguyen, T., & Pham, H. (2026). Selection of capacitation in-vitro maturation (CAPA–IVM) blastocyst embryos by a machine learning prediction model using the morpho-kinetics. Results in Optics, Article 101165. https://doi.org/10.1016/j.rio.2026.101165

Image Credits: AI Generated

DOI: 10.1016/j.rio.2026.101165

Keywords: CAPA-IVM, in vitro maturation, embryo selection, machine learning, morphokinetics, time-lapse monitoring, XGBoost, decision tree, polycystic ovary syndrome, ovarian hyperstimulation syndrome, blastocyst, assisted reproduction